Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Tuettenberg

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Cancer Research and Clinical Oncology|March 12, 2009
Recurrence pattern in glioblastoma multiforme patients treated with anti-angiogenic chemotherapyJochen Tuettenberg, Rainer Grobholz, Marcel Seiz, et al.
Neurosurgical Review|March 23, 2010
Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxibMarcel Seiz, Ingo Nölte, Ioannis Pechlivanis, et al.
Journal of Neuro-Oncology|May 7, 2010
Continuous low-dose temozolomide and celecoxib in recurrent glioblastomaFlorian Stockhammer, Martin Misch, Arend Koch, et al.
Clinical Nuclear Medicine|January 12, 2011
Pharmacokinetic studies of ⁶⁸Ga-labeled Bombesin (⁶⁸Ga-BZH₃) and F-18 FDG PET in patients with recurrent gliomas and comparison to grading: preliminary resultsAntonia Dimitrakopoulou-Strauss, Marcel Seiz, Jochen Tuettenberg, et al.
Acta Neuropathologica|June 2, 2010
Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypesMarcel Seiz, Jochen Tuettenberg, Jochen Meyer, et al.
Hellenic Journal of Nuclear Medicine|December 17, 2008
Differentiation between malignant transformation and tumour recurrence by (68)Ga-bombesin and (18)F-FDG-PET, in patients with low grade gliomasMarcel Seiz, Antonia Dimitrakopoulou-Strauss, Gerrit A Schubert, et al.
Journal of Neurosurgery|March 3, 2009
Clinical evaluation of the safety and efficacy of lumbar cerebrospinal fluid drainage for the treatment of refractory increased intracranial pressureJochen Tuettenberg, Marcus Czabanka, Peter Horn, et al.
Heliyon|December 11, 2023
Development of a bleeding scale and hemostasis algorithm in cranial neurosurgeryIlker Y Eyüpoglu, Jochen Tuettenberg, Karl-Michael Schebesch, et al.
Molecular Imaging and Biology|July 12, 2011
Correlation of the Ga-68-bombesin analog Ga-68-BZH3 with receptors expression in gliomas as measured by quantitative dynamic positron emission tomography (dPET) and gene arraysLudwig G Strauss, Dirk Koczan, Marcel Seiz, et al.
International Journal of Molecular Sciences|July 31, 2019
GARP as an Immune Regulatory Molecule in the Tumor Microenvironment of Glioblastoma MultiformeNiklas Zimmer, Ella Kim, Bettina Sprang, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Cancer Research and Clinical Oncology|March 12, 2009
Recurrence pattern in glioblastoma multiforme patients treated with anti-angiogenic chemotherapyJochen Tuettenberg, Rainer Grobholz, Marcel Seiz, et al.
Neurosurgical Review|March 23, 2010
Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxibMarcel Seiz, Ingo Nölte, Ioannis Pechlivanis, et al.
Journal of Neuro-Oncology|May 7, 2010
Continuous low-dose temozolomide and celecoxib in recurrent glioblastomaFlorian Stockhammer, Martin Misch, Arend Koch, et al.
Clinical Nuclear Medicine|January 12, 2011
Pharmacokinetic studies of ⁶⁸Ga-labeled Bombesin (⁶⁸Ga-BZH₃) and F-18 FDG PET in patients with recurrent gliomas and comparison to grading: preliminary resultsAntonia Dimitrakopoulou-Strauss, Marcel Seiz, Jochen Tuettenberg, et al.
Acta Neuropathologica|June 2, 2010
Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypesMarcel Seiz, Jochen Tuettenberg, Jochen Meyer, et al.
Hellenic Journal of Nuclear Medicine|December 17, 2008
Differentiation between malignant transformation and tumour recurrence by (68)Ga-bombesin and (18)F-FDG-PET, in patients with low grade gliomasMarcel Seiz, Antonia Dimitrakopoulou-Strauss, Gerrit A Schubert, et al.
Journal of Neurosurgery|March 3, 2009
Clinical evaluation of the safety and efficacy of lumbar cerebrospinal fluid drainage for the treatment of refractory increased intracranial pressureJochen Tuettenberg, Marcus Czabanka, Peter Horn, et al.
Heliyon|December 11, 2023
Development of a bleeding scale and hemostasis algorithm in cranial neurosurgeryIlker Y Eyüpoglu, Jochen Tuettenberg, Karl-Michael Schebesch, et al.
Molecular Imaging and Biology|July 12, 2011
Correlation of the Ga-68-bombesin analog Ga-68-BZH3 with receptors expression in gliomas as measured by quantitative dynamic positron emission tomography (dPET) and gene arraysLudwig G Strauss, Dirk Koczan, Marcel Seiz, et al.
International Journal of Molecular Sciences|July 31, 2019
GARP as an Immune Regulatory Molecule in the Tumor Microenvironment of Glioblastoma MultiformeNiklas Zimmer, Ella Kim, Bettina Sprang, et al.
Pageof 4